Enanta Pharmaceuticals Inc (ENTA)
Equity Ratio
34.04%
Quarterly · Period ending:
ENTA Equity Ratio
Latest reported34.04%period ending
Latest reported34.04%period ending
ENTA Quarterly Equity Ratio (-505.68% → 34.04%)
Latest values, visible window
High-resolution chart · PNG
ENTA equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 34.0445% | |
| 37.0466% | |
| 38.4188% | |
| 23.0529% | |
| 26.336% | |
| 28.9598% | |
| 32.0719% | |
| 34.1997% | |
| 37.3388% | |
| 40.1671% | |
| 44.7805% | |
| 46.8844% | |
| 48.0278% | |
| 82.5177% | |
| 86.5633% | |
| 84.4305% | |
| 87.7494% | |
| 88.1433% | |
| 87.2422% | |
| 90.602% | |
| 92.7657% | |
| 93.2156% | |
| 93.9675% | |
| 92.826% | |
| 93.9131% | |
| 94.6427% | |
| 94.3858% | |
| 94.4191% | |
| 94.6383% | |
| 94.5041% | |
| 93.9718% | |
| 95.0394% | |
| 95.2032% | |
| 94.0077% | |
| 93.2085% | |
| 92.3582% | |
| 94.5725% | |
| 95.3588% | |
| 96.332% | |
| 95.968% | |
| 95.4149% | |
| 94.6093% | |
| 94.935% | |
| 95.9937% | |
| 96.008% | |
| 91.1873% | |
| 89.9205% | |
| 95.6497% | |
| 95.8869% | |
| 93.8798% | |
| 95.8442% | |
| 94.4389% | |
| 95.6046% | |
| 94.2274% | |
| 91.3566% | |
| 84.2165% | |
| -202.9452% | |
| -505.6752% |